Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
265,957,447
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
47,753,322
-
Shares change
-
-3,958,122
-
Total reported value, excl. options
-
$759,751,328
-
Value change
-
-$60,798,422
-
Put/Call ratio
-
823%
-
Number of buys
-
65
-
Number of sells
-
-67
-
Price
-
$15.93
Significant Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) as of Q3 2022
161 filings reported holding OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q3 2022.
Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,753,322 shares
of 265,957,447 outstanding shares and own 18% of the company stock.
Largest 10 shareholders include FMR LLC (7,201,095 shares), JPMORGAN CHASE & CO (5,044,955 shares), VANGUARD GROUP INC (4,491,145 shares), BlackRock Inc. (3,308,651 shares), T. Rowe Price Investment Management, Inc. (3,173,126 shares), Bellevue Group AG (2,417,456 shares), Champlain Investment Partners, LLC (1,939,585 shares), STATE STREET CORP (1,254,783 shares), Eagle Health Investments LP (1,237,990 shares), and PERCEPTIVE ADVISORS LLC (1,168,630 shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.